Clinical course of subepithelial lesions

Feb 05, 2010

Although several studies pertaining to the natural history of subepithelial tumors have been published, they have been limited by small sample size and relatively short follow-up. The natural history of subepithelial lesions has not been clearly elucidated, and the appropriate management strategy for small subepithelial tumors is still controversial.

A research article to be published on January 28, 2010 in the addresses this question. The research team from South Korea reviewed the medical records of 104 159 patients who underwent upper gastrointestinal endoscopy at the Center for Health Promotion of Samsung Medical Center between 1996 and 2003.

Their results showed that of the 252 lesions, 244 (96.8%) were unchanged. And endoscopic surveillance can be an appropriate strategy for < 1 cm. further prospective, multicenter studies with long-term follow-up would help to validate these surveillance programs.

Explore further: New type of targeted therapy shows promise in preclinical models of B-cell malignancy

More information: Lim YJ, Son HJ, Lee JS, Byun YH, Suh HJ, Rhee PL, Kim JJ, Rhee JC. Clinical course of subepithelial lesions detected on upper gastrointestinal endoscopy. World J Gastroenterol 2010; 16(4): 439-444, www.wjgnet.com/1007-9327/16/439.asp

add to favorites email to friend print save as pdf

Related Stories

A new screening test for chronic abdominal pain

Dec 29, 2008

Evaluation of chronic abdominal pain of luminal etiology is a challenging problem for the primary care physicians and gastroenterologists. The exact localization of lesion to either small or large bowel remains an elusive ...

Recommended for you

The fine line between breast cancer and normal tissues

15 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

16 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

18 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

User comments : 0